HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Inoue Selected Research

1- (2- (1- adamantyl)ethyl)- 1- pentyl- 3- (3- (4- pyridyl)propyl)urea

2/2010Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents.
1/2010Effects of SA13353, a transient receptor potential vanilloid 1 agonist, on leukocyte infiltration in lipopolysaccharide-induced acute lung injury and ovalbumin-induced allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Inoue Research Topics

Disease

74Neoplasms (Cancer)
04/2022 - 09/2005
15Neoplasm Metastasis (Metastasis)
01/2022 - 01/2009
11Prostatic Neoplasms (Prostate Cancer)
01/2020 - 04/2006
9Adenocarcinoma
03/2022 - 01/2012
9Infections
10/2021 - 08/2005
9Atrial Fibrillation
01/2021 - 10/2017
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2010
7Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 01/2012
7Carcinoma (Carcinomatosis)
10/2020 - 09/2008
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2020 - 04/2015
5Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2009
5Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 09/2013
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2012
4Hepatocellular Carcinoma (Hepatoma)
10/2019 - 04/2015
4Thyroid Neoplasms (Thyroid Cancer)
01/2017 - 01/2011
4Papillary Thyroid Cancer
11/2011 - 01/2009
4Papillary Carcinoma
11/2010 - 09/2008
3Lung Neoplasms (Lung Cancer)
06/2021 - 09/2005
3Carcinogenesis
04/2017 - 12/2009
3Melanoma (Melanoma, Malignant)
09/2016 - 01/2016
3Seizures (Absence Seizure)
04/2013 - 07/2003
3Inflammation (Inflammations)
08/2012 - 01/2010
3Lymphatic Metastasis
01/2010 - 01/2009
2Hypertension (High Blood Pressure)
01/2022 - 01/2022
2Wounds and Injuries (Trauma)
10/2021 - 11/2011
2Hypothermia
01/2021 - 11/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 03/2007
2Left Ventricular Dysfunction
01/2021 - 01/2018
2COVID-19
11/2020 - 01/2020
2Atrial Premature Complexes (Premature Atrial Contraction)
01/2020 - 11/2019
2Poisoning
01/2020 - 01/2012
2Pleural Effusion (Pleural Effusions)
12/2019 - 07/2018
2Hemorrhage
04/2019 - 02/2015
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 07/2016
2Heart Arrest (Cardiac Arrest)
11/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2008
8Immune Checkpoint InhibitorsIBA
06/2021 - 01/2016
8Pharmaceutical PreparationsIBA
01/2020 - 07/2003
6Biomarkers (Surrogate Marker)IBA
08/2022 - 07/2012
6Monoclonal AntibodiesIBA
01/2021 - 11/2017
6Biological ProductsIBA
07/2014 - 10/2008
5GemcitabineFDA Link
01/2021 - 07/2012
5AntibodiesIBA
01/2021 - 09/2008
5Peptides (Polypeptides)IBA
01/2020 - 01/2016
5AntigensIBA
01/2018 - 09/2008
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2014 - 10/2006
4NivolumabIBA
08/2022 - 01/2016
4Adenosine Triphosphate (ATP)IBA
06/2021 - 05/2012
4Insulin-Like Growth Factor I (IGF-1)IBA
01/2020 - 04/2006
4CytokinesIBA
12/2019 - 10/2006
4Cancer VaccinesIBA
01/2016 - 09/2008
3intervenolinIBA
12/2021 - 05/2013
3CeramidasesIBA
10/2021 - 02/2009
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2020
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2006
3Insulin (Novolin)FDA Link
01/2021 - 10/2012
3Immunoglobulin G (IgG)IBA
10/2020 - 07/2010
3Phosphotransferases (Kinase)IBA
10/2020 - 03/2016
3DNA (Deoxyribonucleic Acid)IBA
07/2020 - 04/2014
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2018 - 01/2016
3Tumor Biomarkers (Tumor Markers)IBA
01/2018 - 01/2011
3Equilibrative Nucleoside Transporter 1IBA
05/2016 - 07/2012
3Methamphetamine (Desoxyn)FDA LinkGeneric
12/2008 - 06/2003
2C-Reactive ProteinIBA
08/2022 - 06/2021
2Cisplatin (Platino)FDA LinkGeneric
04/2022 - 01/2021
2Lactic Acid (Lactate)FDA LinkGeneric
12/2021 - 01/2021
2AnticoagulantsIBA
11/2021 - 04/2019
2Capsules (Microcapsules)IBA
11/2021 - 01/2015
2Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
10/2021 - 03/2010
2cytostatinIBA
10/2021 - 03/2010
2HMGB1 Protein (HMG1)IBA
06/2021 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2010
2CalreticulinIBA
01/2021 - 05/2012
2osimertinibIBA
01/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
07/2020 - 07/2020
2Insulin-Like PeptidesIBA
01/2020 - 04/2006
2Immune Checkpoint ProteinsIBA
01/2020 - 12/2019
2leucinostatin AIBA
01/2020 - 02/2010
2LigandsIBA
12/2019 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2019 - 12/2009
2Complement System Proteins (Complement)IBA
11/2019 - 11/2017
2adenovirus receptorIBA
11/2019 - 11/2017

Therapy/Procedure

34Therapeutics
08/2022 - 09/2005
10Catheter Ablation
01/2021 - 10/2017
9Thyroidectomy
01/2017 - 09/2008
8Drug Therapy (Chemotherapy)
06/2021 - 03/2007
8Immunotherapy
01/2019 - 11/2010
6Neck Dissection (Radical Neck Dissection)
11/2011 - 06/2006
4Hepatectomy
10/2021 - 11/2017
4Transplantation
07/2020 - 04/2015
4Chemoradiotherapy
06/2018 - 07/2012
4Lymph Node Excision (Lymph Node Dissection)
11/2017 - 01/2009
3Extracorporeal Membrane Oxygenation
01/2020 - 01/2017
2Gastrectomy
01/2022 - 01/2009
2Renal Dialysis (Hemodialysis)
11/2021 - 10/2010
2Stents
07/2021 - 07/2012
2Neoadjuvant Therapy
01/2021 - 01/2012
2Precision Medicine
01/2021 - 06/2018
2Self Expandable Metallic Stents
01/2021 - 02/2016
2Radiofrequency Ablation
01/2019 - 11/2017